|
1
|
Shi W, Lu T, Xu-Monette Y, Young KH. Encouraging prospects with sugemalimab in relapsed or refractory extranodal natural killer/T-cell lymphoma. Chin Clin Oncol 2024; 13:17. [PMID: 38073311 DOI: 10.21037/cco-23-69] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2023] [Accepted: 10/29/2023] [Indexed: 03/09/2024]
Affiliation(s)
- Wenyu Shi
- Division of Hematopathology, Department of Pathology, Duke University Medical Center, Durham, NC, USA
| | - Tingxun Lu
- Division of Hematopathology, Department of Pathology, Duke University Medical Center, Durham, NC, USA
| | - Yidan Xu-Monette
- Division of Hematopathology, Department of Pathology, Duke University Medical Center, Durham, NC, USA
| | - Ken H Young
- Division of Hematopathology, Department of Pathology, Duke University Medical Center, Durham, NC, USA
| |
Collapse
|